It has been shown that Arid5a enables mesenchymal tumor models of PDAC and CRC to facilitate immune evasiveness via promoting the tumor infiltration of immunosuppressive granulocytic MDSCs and Tregs and reducing the recruitment and activation of antitumor effector T cells [206]. Here, ARID5A is linked to mesenchymal cell neoplasm.